$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
06:21am, Sunday, 17'th Oct 2021
These stocks are expected to put up big gains in a short amount of time.
Is It Too Late to Buy ChemoCentryx Stock?
07:18am, Thursday, 14'th Oct 2021
The stock surged after obtaining FDA approval for avacopan.
2 Super-Charged Growth Stocks to Buy Now
10:00am, Wednesday, 13'th Oct 2021
These two small drugmakers are poised for a long-winded growth spurt.
BZ Chart Of The Day: ChemoCentryx
11:43am, Monday, 11'th Oct 2021
There's an old saying on Wall Street that "gaps refill." It's true and it may be about to happen to shares of ChemoCentryx, Inc. (NASDAQ:CCXI).
CCXI Stock: Why It Increased Today
10:17am, Monday, 11'th Oct 2021
The stock price of ChemoCentryx Inc (NASDAQ: CCXI) increased by over 9% during intraday trading today. This is why it happened.
ChemoCentryx Appoints Rita I. Jain, M.D.
08:30am, Monday, 11'th Oct 2021
Appointment Brings More than 20 Years of Drug Development Experience as Company Launches First Product
Why ChemoCentryx Stock Skyrocketed Today
05:40pm, Friday, 08'th Oct 2021
Investors are excited about the biotech's game-changing new drug.
Should you buy ChemoCentryx stock as shares spike 70% on avacopan approval?
04:30pm, Friday, 08'th Oct 2021
On Friday, ChemoCentryx Inc. (NASDAQ:CCXI) shares spiked nearly 70% after announcing the Food and Drug Administration (FDA) had approved avacopan for the treatment of ANCA vasculitis. Avacopan is an o
ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks
01:10pm, Friday, 08'th Oct 2021
The broader market was mixed on Friday.
CCXI Stock Price: Why It Increased By Over 88% Today
11:11am, Friday, 08'th Oct 2021
The stock price of ChemoCentryx Inc (NASDAQ: CCXI) increased by over 88% during intraday trading today. This is why it happened.
Here's why ChemoCentryx is up 50% on Friday morning
10:46am, Friday, 08'th Oct 2021
ChemoCentryx Inc (NASDAQ: CCXI) shareholders had every reason to be happy about on Friday morning. The shares of the group traded higher on Friday morning, thanks to the announcement made by the group
ChemoCentryx (CCXI) Soars 5.4%: Is Further Upside Left in the Stock?
08:49am, Friday, 08'th Oct 2021
ChemoCentryx (CCXI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more streng
ChemoCentryx's stock jumps 80% after receiving FDA approval for vasculitis drug
08:24am, Friday, 08'th Oct 2021
Shares of ChemoCentryx Inc. CCXI, +5.43% soared 80.3% in premarket trading on Friday after the company said that it had received approval from the Food and Drug Administration for its ANCA-associated
Why Did ChemoCentryx Shares Soar 70% On Friday Premarket?
08:02am, Friday, 08'th Oct 2021
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis o
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis
07:00am, Friday, 08'th Oct 2021
-- First FDA-approved orally-administered inhibitor of the complement 5a receptor -- -- Company to hold conference call at 8:30 a.m. Eastern Time --
Sign In
Buy CCXI